We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+24.34%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.08B
AUM Growth
-$1.3B
Cap. Flow
-$1.79B
Cap. Flow %
-86.14%
Top 10 Hldgs %
46.37%
Holding
64
New
8
Increased
12
Reduced
35
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.5M
2
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$23.2M
3
CLDX icon
Celldex Therapeutics
CLDX
+$21.6M
4
PFE icon
Pfizer
PFE
+$19.8M
5
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$19.6M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$151M
2
VTRS icon
Viatris
VTRS
+$125M
3
BSX icon
Boston Scientific
BSX
+$123M
4
AGN
Allergan plc
AGN
+$123M
5
EW icon
Edwards Lifesciences
EW
+$118M

Sector Composition

Rank Sector Weight
1 Healthcare 86.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
26
Illumina
ILMN
$28.7B
$28.3M 1.36%
360,200
-1,015,664
-74% -$77.7M
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
$25.9M 1.25%
426,200
+213,500
+100% +$15.1M
PTLA
28
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$25.9M 1.24%
966,786
-167,252
-15% -$3.98M
PCYC
29
DELISTED
PHARMACYCLICS INC
PCYC
$23.3M 1.12%
168,425
-318,799
-65% -$35.4M
INSM icon
30
Insmed
INSM
$22.7B
$22.6M 1.09%
+1,446,821
New +$18.4M
VPHM
31
DELISTED
VIROPHARMA INC
VPHM
$21.8M 1.05%
556,024
-3,700
-0.7% -$121K
COV
32
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$20.7M 1%
339,812
-193,204
-36% -$11.8M
PFE icon
33
Pfizer
PFE
$141B
$19.8M 0.95%
+727,973
New +$19.8M
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
$18.5M 0.89%
422,619
+850
+0.2% +$35.4K
ALGN icon
35
Align Technology
ALGN
$12B
$17.9M 0.86%
371,438
-2,013,968
-84% -$87.9M
BSX icon
36
Boston Scientific
BSX
$67.6B
$17.4M 0.84%
1,485,072
-11,379,049
-88% -$123M
RDY icon
37
Dr. Reddy's Laboratories
RDY
$9.8B
$16.7M 0.8%
2,211,700
+19,500
+0.9% +$142K
IONS icon
38
Ionis Pharmaceuticals
IONS
$9.25B
$16.6M 0.8%
+441,401
New +$13.2M
TEVA icon
39
Teva Pharmaceuticals
TEVA
$36.2B
$16.4M 0.79%
434,049
+26,300
+6% +$1.03M
OMED
40
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$16.2M 0.78%
+1,059,479
New +$19.6M
AKRX
41
DELISTED
Akorn Inc
AKRX
$14.5M 0.7%
737,082
-55,700
-7% -$901K
NXTM
42
DELISTED
NxStage Medical Inc.
NXTM
$14.5M 0.7%
1,101,000
-2,454,725
-69% -$32.2M
EVAC
43
DELISTED
EDWARDS GROUP LTD ADR (CYM)
EVAC
$13.7M 0.66%
+196,669
New +$1.78M
MNTA
44
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$12.3M 0.59%
852,096
+5,900
+0.7% +$90.3K
SGNT
45
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$11.5M 0.55%
564,325
-45,731
-7% -$1.02M
MNK
46
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$11.1M 0.54%
+252,764
New +$11.1M
TRNX
47
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$8.34M 0.4%
431,520
-5,746
-1% -$107K
HTWR
48
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$7.86M 0.38%
107,351
-498,596
-82% -$42.5M
HOLX
49
DELISTED
Hologic
HOLX
$7.78M 0.37%
376,532
-2,280,022
-86% -$48.5M
ARAY icon
50
Accuray
ARAY
$26.8M
$6.91M 0.33%
936,352
-201,416
-18% -$1.27M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2013 Portfolio in Review

As of Q3 2013, Sectoral Asset Management held 64 positions worth $2.08B, down 39% from $3.38B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sectoral Asset Management withdrew a net $1.79B in Q3 2013, closing 9 positions and reducing 35 holdings. Its most notable exit was Edwards Lifesciences, an estimated $118M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 84% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in SYNAGEVA BIOPHARMA CORP COM STK (DE) worth $29.9M.

  • Sectoral Asset Management's largest Q3 2013 buy was SYNAGEVA BIOPHARMA CORP COM STK (DE): 470,950 shares worth $29.9M.
  • Sectoral Asset Management added most to Amgen in Q3 2013, an estimated $41.5M increase.
  • Sectoral Asset Management's biggest Q3 2013 reduction was Incyte, cutting an estimated $151M.
  • Sectoral Asset Management fully exited Edwards Lifesciences in Q3 2013, selling an estimated $118M.
  • Sectoral Asset Management's ten largest holdings make up 46% of its $2.08B portfolio in Q3 2013.
  • Sectoral Asset Management opened 8 new positions and closed 9 in Q3 2013.
  • Sectoral Asset Management's portfolio value fell 39% quarter-over-quarter to $2.08B.

Based on Sectoral Asset Management's 13F filing for Q3 2013, filed 13 Nov 2013.